DISEASE INDICATIONS: Diabetes

MANUFACTURER: Zeeland Pharma

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Zegalogue (dasiglucagon) is a medication used to treat severe hypoglycemia in people with diabetes, approved by the US Food and Drug Administration in March 2021. It is a soluble glucagon analog that can be injected via a prefilled, single-use injector device, and stimulates the liver to increase blood sugar levels.